Search results for: Innovation Policy Prize
Filter search results
Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation
21 February 2020
…global health innovation ecosystem, payer policy remains an understudied and neglected function within the innovation value chain. By systematically and strategically strengthening payer policy, potentially aided through the establishment of…
A Spotlight on Haemophilia Therapies
3 October 2024
…in ensuring a healthy innovation ecosystem, allowing innovation to continue transforming patient lives. For example: Developers, manufacturers, and researchers must continue to invest in R&D, leveraging feedback loops of return…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…volume of innovation that is important, but the value of that innovation. In health care innovation should generate “value” by (1) improving patients’ quality and/or or length of life and/or…
Spotlight on OHE: Innovation, Regulation and Antibiotics
30 September 2014
…research and analyses on innovation and antibiotics are available by clicking here. Understanding the connection between regulation and innovation The Regulatory Policy Institute, based in Oxford, holds an annual conference…
Global rare‑disease policy shifts: what are the implications for equitable access to orphan medicines?
1 March 2026
…therefore especially sensitive to regulatory and policy changes. However, regulatory incentives for orphan drug research and development (R&D) are often not matched by Health Technology Assessment (HTA) and Pricing and…
Charlotte Davies
10 December 2018
…of a new educational arm of OHE; a six–part educational vaccines programme; the new OHE website; the OHE Innovation Policy Prize; and the revision of The Health Economic Dictionary. …
OHE Critique of CBO’S Pharmaceutical Investment Model Provides Warning for Policymakers on Reliability of Estimates
3 December 2021
…policy which alters expected pharmaceutical industry returns (e.g., any policy reducing drug prices) or R&D costs. Based upon this simulation model, the CBO has published estimates of the innovation impacts…
Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation
14 October 2021, 1:00pm
…and distribution bottlenecks while jeopardising future innovation. For OHE’s Annual Lecture 2021, Professor Kyle will deliver a talk entitled Do patents work? Evidence from pharmaceutical innovation. She will describe the…
Adrian Towse named 2018 Value Assessment Challenge Award Recipient
22 October 2018
…Development and Use of innovations in Personalized and Precision Medicine,” Garrison and Towse call for a broadening of the concepts of value in personalized/precision medicine, laying out six basic policy…